世界の予防用ヒトワクチン市場：市場規模・現状・予測

• 英文タイトル：Global Prophylactic Human Vaccines Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9N7890
• 出版社/出版日：QYResearch / 2019年6月14日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、107ページ
• 納品方法：Eメール（受注後２～3営業日）
• 産業分類：医療・製薬・バイオ

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当資料は、予防用ヒトワクチンのグローバル市場について調査・分析したレポートで、種類別（タイプI、タイプII）、用途別（小児予防ワクチン、成人予防ワクチン）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・予防用ヒトワクチンの世界市場規模
・主要企業別市場シェア
・予防用ヒトワクチンの世界市場規模：種類別（タイプI、タイプII）
・予防用ヒトワクチンの世界市場規模：用途別（小児予防ワクチン、成人予防ワクチン）
・予防用ヒトワクチンのアメリカ市場規模（種類別、用途別）
・予防用ヒトワクチンのヨーロッパ市場規模（種類別、用途別）
・予防用ヒトワクチンの中国市場規模（種類別、用途別）
・予防用ヒトワクチンの日本市場規模（種類別、用途別）
・予防用ヒトワクチンの東南アジア市場規模（種類別、用途別）
・予防用ヒトワクチンのインド市場規模（種類別、用途別）
・予防用ヒトワクチンの中南米市場規模（種類別、用途別）
・主要企業別分析（企業概要、製品動向、販売量など）
・予防用ヒトワクチンの世界市場予測（2019年-2025年）
・予防用ヒトワクチンの地域別市場予測（2019年-2025年）
...

In 2018, the global Prophylactic Human Vaccines market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Prophylactic Human Vaccines status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Prophylactic Human Vaccines development in United States, Europe and China.

The key players covered in this study
ALK
Altimmune
Bavarian Nordic
BiondVax Pharmaceuticals
Bharat Biotech International
GlaxoSmithKline
Hualan Biological Engineering
Janssen Pharmaceuticals
MedImmune
Merck
Pfizer
Sanofi Pasteur
Serum Institute of India
Shanghai BravoBio
Seqirus
SK Chemicals
Takeda Pharmaceutical Company
Zydus Cadila

Market segment by Type, the product can be split into
Type I
Type II

Market segment by Application, split into
Pediatric Prophylactic Vaccines
Adult Prophylactic Vaccines

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Prophylactic Human Vaccines status, future forecast, growth opportunity, key market and key players.
To present the Prophylactic Human Vaccines development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Prophylactic Human Vaccines are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Prophylactic Human Vaccines Market Size Growth Rate by Type (2014-2025)
1.4.2 Type I
1.4.3 Type II
1.5 Market by Application
1.5.1 Global Prophylactic Human Vaccines Market Share by Application (2014-2025)
1.5.2 Pediatric Prophylactic Vaccines
1.5.3 Adult Prophylactic Vaccines
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Prophylactic Human Vaccines Market Size
2.2 Prophylactic Human Vaccines Growth Trends by Regions
2.2.1 Prophylactic Human Vaccines Market Size by Regions (2014-2025)
2.2.2 Prophylactic Human Vaccines Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Prophylactic Human Vaccines Market Size by Manufacturers
3.1.1 Global Prophylactic Human Vaccines Revenue by Manufacturers (2014-2019)
3.1.2 Global Prophylactic Human Vaccines Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Prophylactic Human Vaccines Market Concentration Ratio (CR5 and HHI)
3.2 Prophylactic Human Vaccines Key Players Head office and Area Served
3.3 Key Players Prophylactic Human Vaccines Product/Solution/Service
3.4 Date of Enter into Prophylactic Human Vaccines Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Prophylactic Human Vaccines Market Size by Type (2014-2019)
4.2 Global Prophylactic Human Vaccines Market Size by Application (2014-2019)

5 United States
5.1 United States Prophylactic Human Vaccines Market Size (2014-2019)
5.2 Prophylactic Human Vaccines Key Players in United States
5.3 United States Prophylactic Human Vaccines Market Size by Type
5.4 United States Prophylactic Human Vaccines Market Size by Application

6 Europe
6.1 Europe Prophylactic Human Vaccines Market Size (2014-2019)
6.2 Prophylactic Human Vaccines Key Players in Europe
6.3 Europe Prophylactic Human Vaccines Market Size by Type
6.4 Europe Prophylactic Human Vaccines Market Size by Application

7 China
7.1 China Prophylactic Human Vaccines Market Size (2014-2019)
7.2 Prophylactic Human Vaccines Key Players in China
7.3 China Prophylactic Human Vaccines Market Size by Type
7.4 China Prophylactic Human Vaccines Market Size by Application

8 Japan
8.1 Japan Prophylactic Human Vaccines Market Size (2014-2019)
8.2 Prophylactic Human Vaccines Key Players in Japan
8.3 Japan Prophylactic Human Vaccines Market Size by Type
8.4 Japan Prophylactic Human Vaccines Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Prophylactic Human Vaccines Market Size (2014-2019)
9.2 Prophylactic Human Vaccines Key Players in Southeast Asia
9.3 Southeast Asia Prophylactic Human Vaccines Market Size by Type
9.4 Southeast Asia Prophylactic Human Vaccines Market Size by Application

10 India
10.1 India Prophylactic Human Vaccines Market Size (2014-2019)
10.2 Prophylactic Human Vaccines Key Players in India
10.3 India Prophylactic Human Vaccines Market Size by Type
10.4 India Prophylactic Human Vaccines Market Size by Application

11 Central & South America
11.1 Central & South America Prophylactic Human Vaccines Market Size (2014-2019)
11.2 Prophylactic Human Vaccines Key Players in Central & South America
11.3 Central & South America Prophylactic Human Vaccines Market Size by Type
11.4 Central & South America Prophylactic Human Vaccines Market Size by Application

12 International Players Profiles
12.1 ALK
12.1.1 ALK Company Details
12.1.2 Company Description and Business Overview
12.1.3 Prophylactic Human Vaccines Introduction
12.1.4 ALK Revenue in Prophylactic Human Vaccines Business (2014-2019)
12.1.5 ALK Recent Development
12.2 Altimmune
12.2.1 Altimmune Company Details
12.2.2 Company Description and Business Overview
12.2.3 Prophylactic Human Vaccines Introduction
12.2.4 Altimmune Revenue in Prophylactic Human Vaccines Business (2014-2019)
12.2.5 Altimmune Recent Development
12.3 Bavarian Nordic
12.3.1 Bavarian Nordic Company Details
12.3.2 Company Description and Business Overview
12.3.3 Prophylactic Human Vaccines Introduction
12.3.4 Bavarian Nordic Revenue in Prophylactic Human Vaccines Business (2014-2019)
12.3.5 Bavarian Nordic Recent Development
12.4 BiondVax Pharmaceuticals
12.4.1 BiondVax Pharmaceuticals Company Details
12.4.2 Company Description and Business Overview
12.4.3 Prophylactic Human Vaccines Introduction
12.4.4 BiondVax Pharmaceuticals Revenue in Prophylactic Human Vaccines Business (2014-2019)
12.4.5 BiondVax Pharmaceuticals Recent Development
12.5 Bharat Biotech International
12.5.1 Bharat Biotech International Company Details
12.5.2 Company Description and Business Overview
12.5.3 Prophylactic Human Vaccines Introduction
12.5.4 Bharat Biotech International Revenue in Prophylactic Human Vaccines Business (2014-2019)
12.5.5 Bharat Biotech International Recent Development
12.6 GlaxoSmithKline
12.6.1 GlaxoSmithKline Company Details
12.6.2 Company Description and Business Overview
12.6.3 Prophylactic Human Vaccines Introduction
12.6.4 GlaxoSmithKline Revenue in Prophylactic Human Vaccines Business (2014-2019)
12.6.5 GlaxoSmithKline Recent Development
12.7 Hualan Biological Engineering
12.7.1 Hualan Biological Engineering Company Details
12.7.2 Company Description and Business Overview
12.7.3 Prophylactic Human Vaccines Introduction
12.7.4 Hualan Biological Engineering Revenue in Prophylactic Human Vaccines Business (2014-2019)
12.7.5 Hualan Biological Engineering Recent Development
12.8 Janssen Pharmaceuticals
12.8.1 Janssen Pharmaceuticals Company Details
12.8.2 Company Description and Business Overview
12.8.3 Prophylactic Human Vaccines Introduction
12.8.4 Janssen Pharmaceuticals Revenue in Prophylactic Human Vaccines Business (2014-2019)
12.8.5 Janssen Pharmaceuticals Recent Development
12.9 MedImmune
12.9.1 MedImmune Company Details
12.9.2 Company Description and Business Overview
12.9.3 Prophylactic Human Vaccines Introduction
12.9.4 MedImmune Revenue in Prophylactic Human Vaccines Business (2014-2019)
12.9.5 MedImmune Recent Development
12.10 Merck
12.10.1 Merck Company Details
12.10.2 Company Description and Business Overview
12.10.3 Prophylactic Human Vaccines Introduction
12.10.4 Merck Revenue in Prophylactic Human Vaccines Business (2014-2019)
12.10.5 Merck Recent Development
12.11 Pfizer
12.12 Sanofi Pasteur
12.13 Serum Institute of India
12.14 Shanghai BravoBio
12.15 Seqirus
12.16 SK Chemicals
12.17 Takeda Pharmaceutical Company
12.18 Zydus Cadila

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Prophylactic Human Vaccines Key Market Segments
Table Key Players Prophylactic Human Vaccines Covered
Table Global Prophylactic Human Vaccines Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Prophylactic Human Vaccines Market Size Market Share by Type 2014-2025
Figure Type I Figures
Table Key Players of Type I
Figure Type II Figures
Table Key Players of Type II
Table Global Prophylactic Human Vaccines Market Size Growth by Application 2014-2025 (Million US$)
Figure Pediatric Prophylactic Vaccines Case Studies
Figure Adult Prophylactic Vaccines Case Studies
Figure Prophylactic Human Vaccines Report Years Considered
Table Global Prophylactic Human Vaccines Market Size 2014-2025 (Million US$)
Figure Global Prophylactic Human Vaccines Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Prophylactic Human Vaccines Market Size by Regions 2014-2025 (Million US$)
Table Global Prophylactic Human Vaccines Market Size by Regions 2014-2019 (Million US$)
Table Global Prophylactic Human Vaccines Market Share by Regions 2014-2019
Figure Global Prophylactic Human Vaccines Market Share by Regions 2014-2019
Figure Global Prophylactic Human Vaccines Market Share by Regions 2019
Table Market Top Trends
Table Global Prophylactic Human Vaccines Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Prophylactic Human Vaccines Market Share by Manufacturers (2014-2019)
Figure Global Prophylactic Human Vaccines Market Share by Manufacturers in 2018
Table Global Prophylactic Human Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Prophylactic Human Vaccines Product/Solution/Service
Table Date of Enter into Prophylactic Human Vaccines Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Prophylactic Human Vaccines Market Size by Type (2014-2019) (Million US$)
Table Global Prophylactic Human Vaccines Market Size Share by Type (2014-2019)
Figure Global Prophylactic Human Vaccines Market Size Market Share by Type (2014-2019)
Table Global Prophylactic Human Vaccines Market Size by Application (2014-2019) (Million US$)
Table Global Prophylactic Human Vaccines Market Size Share by Application (2014-2019)
Figure Global Prophylactic Human Vaccines Market Size Market Share by Application (2014-2019)
Figure Global Prophylactic Human Vaccines Revenue Market Share by Application in 2018
Figure United States Prophylactic Human Vaccines Market Size 2014-2019 (Million US$)
Table United States Key Players Prophylactic Human Vaccines Revenue (2018-2019) (Million US$)
Table United States Key Players Prophylactic Human Vaccines Market Share (2018-2019)
Table United States Prophylactic Human Vaccines Market Size by Type (2014-2019) (Million US$)
Table United States Prophylactic Human Vaccines Market Share by Type (2014-2019)
Table United States Prophylactic Human Vaccines Market Size by Application (2014-2019) (Million US$)
Table United States Prophylactic Human Vaccines Market Share by Application (2014-2019)
Figure Europe Prophylactic Human Vaccines Market Size 2014-2019 (Million US$)
Table Europe Key Players Prophylactic Human Vaccines Revenue (2018-2019) (Million US$)
Table Europe Key Players Prophylactic Human Vaccines Market Share (2018-2019)
Table Europe Prophylactic Human Vaccines Market Size by Type (2014-2019) (Million US$)
Table Europe Prophylactic Human Vaccines Market Share by Type (2014-2019)
Table Europe Prophylactic Human Vaccines Market Size by Application (2014-2019) (Million US$)
Table Europe Prophylactic Human Vaccines Market Share by Application (2014-2019)
Figure China Prophylactic Human Vaccines Market Size 2014-2019 (Million US$)
Table China Key Players Prophylactic Human Vaccines Revenue (2018-2019) (Million US$)
Table China Key Players Prophylactic Human Vaccines Market Share (2018-2019)
Table China Prophylactic Human Vaccines Market Size by Type (2014-20189) (Million US$)
Table China Prophylactic Human Vaccines Market Share by Type (2014-2019)
Table China Prophylactic Human Vaccines Market Size by Application (2014-2019) (Million US$)
Table China Prophylactic Human Vaccines Market Share by Application (2014-2019)
Figure Japan Prophylactic Human Vaccines Market Size 2014-2019 (Million US$)
Table Japan Key Players Prophylactic Human Vaccines Revenue (2018-2019) (Million US$)
Table Japan Key Players Prophylactic Human Vaccines Market Share (2018-2019)
Table Japan Prophylactic Human Vaccines Market Size by Type (2014-2019) (Million US$)
Table Japan Prophylactic Human Vaccines Market Share by Type (2014-2019)
Table Japan Prophylactic Human Vaccines Market Size by Application (2014-2019) (Million US$)
Table Japan Prophylactic Human Vaccines Market Share by Application (2014-2019)
Figure Southeast Asia Prophylactic Human Vaccines Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Prophylactic Human Vaccines Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Prophylactic Human Vaccines Market Share (2018-2019)
Table Southeast Asia Prophylactic Human Vaccines Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Prophylactic Human Vaccines Market Share by Type (2014-2019)
Table Southeast Asia Prophylactic Human Vaccines Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Prophylactic Human Vaccines Market Share by Application (2014-2019)
Figure India Prophylactic Human Vaccines Market Size 2014-2019 (Million US$)
Table India Key Players Prophylactic Human Vaccines Revenue (2018-2019) (Million US$)
Table India Key Players Prophylactic Human Vaccines Market Share (2018-2019)
Table India Prophylactic Human Vaccines Market Size by Type (2014-2019) (Million US$)
Table India Prophylactic Human Vaccines Market Share by Type (2014-2019)
Table India Prophylactic Human Vaccines Market Size by Application (2014-2019) (Million US$)
Table India Prophylactic Human Vaccines Market Share by Application (2014-2019)
Figure Central & South America Prophylactic Human Vaccines Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Prophylactic Human Vaccines Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Prophylactic Human Vaccines Market Share (2018-2019)
Table Central & South America Prophylactic Human Vaccines Market Size by Type (2014-2019) (Million US$)
Table Central & South America Prophylactic Human Vaccines Market Share by Type (2014-2019)
Table Central & South America Prophylactic Human Vaccines Market Size by Application (2014-2019) (Million US$)
Table Central & South America Prophylactic Human Vaccines Market Share by Application (2014-2019)
Table ALK Company Details
Table ALK Revenue in Prophylactic Human Vaccines Business (2014-2019) (Million US$)
Figure ALK Revenue Growth Rate in Prophylactic Human Vaccines Business (2014-2019)
Table ALK Recent Development
Table Altimmune Company Details
Table Altimmune Revenue in Prophylactic Human Vaccines Business (2014-2019)(Million US$)
Figure Altimmune Revenue Growth Rate in Prophylactic Human Vaccines Business (2014-2019)
Table Altimmune Recent Development
Table Bavarian Nordic Company Details
Table Bavarian Nordic Revenue in Prophylactic Human Vaccines Business (2014-2019)(Million US$)
Figure Bavarian Nordic Revenue Growth Rate in Prophylactic Human Vaccines Business (2014-2019)
Table Bavarian Nordic Recent Development
Table BiondVax Pharmaceuticals Company Details
Table BiondVax Pharmaceuticals Revenue in Prophylactic Human Vaccines Business (2014-2019)(Million US$)
Figure BiondVax Pharmaceuticals Revenue Growth Rate in Prophylactic Human Vaccines Business (2014-2019)
Table BiondVax Pharmaceuticals Recent Development
Table Bharat Biotech International Company Details
Table Bharat Biotech International Revenue in Prophylactic Human Vaccines Business (2014-2019)(Million US$)
Figure Bharat Biotech International Revenue Growth Rate in Prophylactic Human Vaccines Business (2014-2019)
Table Bharat Biotech International Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Prophylactic Human Vaccines Business (2014-2019)(Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Prophylactic Human Vaccines Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Hualan Biological Engineering Company Details
Table Hualan Biological Engineering Revenue in Prophylactic Human Vaccines Business (2014-2019)(Million US$)
Figure Hualan Biological Engineering Revenue Growth Rate in Prophylactic Human Vaccines Business (2014-2019)
Table Hualan Biological Engineering Recent Development
Table Janssen Pharmaceuticals Company Details
Table Janssen Pharmaceuticals Revenue in Prophylactic Human Vaccines Business (2014-2019)(Million US$)
Figure Janssen Pharmaceuticals Revenue Growth Rate in Prophylactic Human Vaccines Business (2014-2019)
Table Janssen Pharmaceuticals Recent Development
Table MedImmune Company Details
Table MedImmune Revenue in Prophylactic Human Vaccines Business (2014-2019)(Million US$)
Figure MedImmune Revenue Growth Rate in Prophylactic Human Vaccines Business (2014-2019)
Table MedImmune Recent Development
Table Merck Company Details
Table Merck Revenue in Prophylactic Human Vaccines Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Prophylactic Human Vaccines Business (2014-2019)
Table Merck Recent Development
Table Pfizer Company Details
Table Sanofi Pasteur Company Details
Table Serum Institute of India Company Details
Table Shanghai BravoBio Company Details
Table Seqirus Company Details
Table SK Chemicals Company Details
Table Takeda Pharmaceutical Company Company Details
Table Zydus Cadila Company Details
Table Global Prophylactic Human Vaccines Market Size by Regions (Million US$) 2019-2025
Figure Global Prophylactic Human Vaccines Market Size Share by Regions (2019-2025)
Figure Global Prophylactic Human Vaccines Market Size Share by Regions in 2025
Figure United States Prophylactic Human Vaccines Market Size Forecast (2019-2025)(Million USD)
Figure Europe Prophylactic Human Vaccines Market Size Forecast (2019-2025)(Million USD)
Figure China Prophylactic Human Vaccines Market Size Forecast (2019-2025)(Million USD)
Figure Japan Prophylactic Human Vaccines Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Prophylactic Human Vaccines Market Size Forecast (2019-2025)(Million USD)
Figure India Prophylactic Human Vaccines Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Prophylactic Human Vaccines Market Size Forecast (2019-2025)(Million USD)
Table Global Prophylactic Human Vaccines Market Size by Product (2019-2025) (Million US$)
Figure Global Prophylactic Human Vaccines Market Size by Product (2019-2025)
Figure Global Prophylactic Human Vaccines Market Size by Product in 2025
Table Global Prophylactic Human Vaccines Market Size by Application (2019-2025) (Million US$)
Figure Global Prophylactic Human Vaccines Market Size by Application (2019-2025)
Figure Global Prophylactic Human Vaccines Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介

世界の予防的B型肝炎ウイルスワクチン市場：市場規模・現状・予測

Global Prophylactic Hepatitis B Virus Vaccines Market Size, Status and Forecast 2019-2025
QYR9N7889 2019年6月14日 93Pages
当資料は、予防的B型肝炎ウイルスワクチンのグローバル市場について調査・分析したレポートで、種類別（B型肝炎、肝硬変、肝細胞がん、肝不全）、用途別（病院、診療所）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

世界のワクチンと予防接種市場：市場規模・現状・予測

Global Vaccines & Vaccination Market Size, Status and Forecast 2019-2025
QYR9N8164 2019年6月14日 99Pages
当資料は、ワクチンと予防接種のグローバル市場について調査・分析したレポートで、種類別（サブユニットワクチン、弱毒化生ワクチン、コンジュゲートワクチン、不活化ワクチン、組換えベクターワクチン、その他）、用途別（小児科疾患市場、世界の成人病）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、イ...

世界のRNAベースの治療薬とワクチン市場：市場規模・現状・予測

Global RNA-Based Therapeutics and Vaccines Market Size, Status and Forecast 2019-2025
QYR9N7978 2019年6月14日 97Pages
当資料は、RNAベースの治療薬とワクチンのグローバル市場について調査・分析したレポートで、種類別（RNAベースの治療薬、RNAベースのワクチン）、用途別（腫瘍学、免疫学、眼科、心血管疾患、感染症、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測...

世界の樹状細胞がんワクチン市場：市場規模・現状・予測

Global Dendritic Cell Cancer Vaccines Market Size, Status and Forecast 2019-2025
QYR9N7076 2019年6月14日 108Pages
当資料は、樹状細胞がんワクチンのグローバル市場について調査・分析したレポートで、種類別（CreaVax、Sipuleucel-T（プロバンジ）、その他）、用途別（小児、大人）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれてい...

世界の組換えヒトアルブミン市場：市場規模・現状・予測

Global Recombinant Human Albumin Market Size, Status and Forecast 2019-2025
QYR9N7941 2019年6月14日 95Pages
当資料は、組換えヒトアルブミンのグローバル市場について調査・分析したレポートで、種類別（OsrHSA
、ScrHSA
）、用途別（細胞培養培地、医療サプリメント、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業...

世界のヒトミクロバイオーム市場：市場規模・現状・予測

Global Human Micobiome Market Size, Status and Forecast 2019-2025
QYR9N7320 2019年6月14日 101Pages
当資料は、ヒトミクロバイオームのグローバル市場について調査・分析したレポートで、種類別（消化管ヒトマイクロバイオーム、尿生殖路ヒトマイクロバイオーム、その他）、用途別（治療、診断）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含ま...

世界のヒトマイクロバイオーム市場：市場規模・現状・予測

Global Human Microbiome Market Size, Status and Forecast 2019-2025
QYR9N7321 2019年6月14日 101Pages
当資料は、ヒトマイクロバイオームのグローバル市場について調査・分析したレポートで、種類別（消化管ヒトマイクロバイオーム、尿生殖路ヒトマイクロバイオーム、その他）、用途別（治療、診断）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含...

世界のヒト免疫不全ウイルス（HIV）市場：市場規模・現状・予測

Global Human Immunodeficiency Virus(HIV) Market Size, Status and Forecast 2019-2025
QYR9N7319 2019年6月14日 99Pages
当資料は、ヒト免疫不全ウイルス（HIV）のグローバル市場について調査・分析したレポートで、種類別（診断、処理）、用途別（病院、外来手術センター、診断センター、在宅ケアの設定、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含...

世界の人間の生殖技術市場：市場規模・現状・予測

Global Human Reproductive Technologies Market Size, Status and Forecast 2019-2025
QYR9N7322 2019年6月14日 96Pages
当資料は、人間の生殖技術のグローバル市場について調査・分析したレポートで、種類別（体外受精（IVF）、細胞質内精子注入法（ICSI）、卵子内卵巣内移行（ZIFT）、配偶子内卵巣内移行（GIFT）、子宮内授精（IUI）、その他）、用途別（病院、不妊治療クリニック）、主要地域別（アメリカ、ヨーロッパ、中...

世界のヒト胚性幹細胞アッセイ市場：市場規模・現状・予測

Global Human Embryonic Stem Cell Assay Market Size, Status and Forecast 2019-2025
QYR9N7318 2019年6月14日 98Pages
当資料は、ヒト胚性幹細胞アッセイのグローバル市場について調査・分析したレポートで、種類別（生存率/細胞毒性、単離と精製、細胞同定、増殖、分化、その他）、用途別（バイオ医薬品＆バイオテクノロジー企業、研究機関）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場...

世界の予防的B型肝炎ウイルスワクチン市場：市場規模・現状・予測 The main objective of hepatitis B immunization strategies is to prevent chronic hepatitis B virus infection and its serious consequences, including liver cirrhosis and hepatocellular cancer.The increasing prevalence and incidence of hepatitis B infection is the dominant factor of driving the growth …
世界のワクチンと予防接種市場：市場規模・現状・予測 Vaccination is the administration of antigenic material (avaccine) to stimulate an individual's immune system to develop adaptive immunity to a pathogen. Vaccines can prevent or ameliorate infectious disease.The increasing popularity of pediatric, travel, addiction, and pediatric combination vaccine…
世界のRNAベースの治療薬とワクチン市場：市場規模・現状・予測 RNA-based biopharmaceuticals, which includes therapeutics and vaccines, is a relatively new class of treatment and prophylactic for a number of chronic and rare diseases, including cancer, diabetes, tuberculosis and certaincardiovascular conditions.RNA-based biopharmaceuticals are a relatively new c…
世界の樹状細胞がんワクチン市場：市場規模・現状・予測 Dendritic cells (DCs) refer to rare kind of leukocytes. They have prompted their recent application to therapeutic cancer vaccinations as they are uniquely effective in their ability to present antigens to T cells. Isolated DCs loaded with tumor antigen ex vivo and administered as a cellular vaccine…
世界のウイルスワクチン市場2019 The global Viral Vaccines market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Viral Vaccines market status and forecast, categorizes the global Viral Vaccines market size (value & volume) by key…